| Symbol |
Name |
|
ACD
|
adrenocortical dysplasia homolog (mouse)
|
|
ASIP
|
agouti signaling protein
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK2AP2
|
cyclin-dependent kinase 2 associated protein 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CHD5
|
chromodomain helicase DNA binding protein 5
|
|
COL17A1
|
collagen, type XVII, alpha 1
|
|
EBF3
|
early B-cell factor 3
|
|
EDNRB
|
endothelin receptor type B
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNA13
|
interferon, alpha 13
|
|
IFNA17
|
interferon, alpha 17
|
|
IFNA2
|
interferon, alpha 2
|
|
IGF2
|
insulin-like growth factor 2
|
|
LAMTOR2
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 2
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
OCA2
|
oculocutaneous albinism II
|
|
PALB2
|
partner and localizer of BRCA2
|
|
POT1
|
protection of telomeres 1
|
|
RASSF7
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7
|
|
RHCE
|
Rh blood group, CcEe antigens
|
|
RPA2
|
replication protein A2, 32kDa
|
|
RPP14
|
ribonuclease P/MRP 14kDa subunit
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A9
|
S100 calcium binding protein A9
|
|
SF3B6
|
splicing factor 3b, subunit 6, 14kDa
|
|
SUB1
|
SUB1 homolog (S. cerevisiae)
|
|
TERF2IP
|
telomeric repeat binding factor 2, interacting protein
|
|
TERT
|
telomerase reverse transcriptase
|
|
TP53
|
tumor protein p53
|